UCLA researchers receive NIH grant to boost the effectiveness of cancer immunotherapy
One day2 outlets reported this in 2 reports over 2 days
All 2 reports on Thu, 6 August 2026
What it is about
Broad Stem Cell Research CenterNational Cancer InstituteDavid Geffen School Of MedicineParker Institute For Cancer ImmunotherapyHealth Jonsson Comprehensive Cancer CenterJacob WassermanKaren BassJim NewtonCristina PuigHiroshi MotomuraInstitute Of TransportationPolitics InstitutePhiladelphia, Pennsylvania, United StatesLos Angeles, California, United StatesCalifornians, United StatesNew York, United StatesFresno, California, United StatesWashington, Washington, United StatesAltadena, California, United StatesCalifornia, United States
Who published it, and when
original reportfirst to report
newswise.com
ucla.edu
6 Aug, 00:50over 20 hours6 Aug, 20:27
How it spread - 2 original reports
Thu, 6 August 2026
2 reports- newswise.com00:50first to report
Dr. Cristina Puig-Saus and her team are studying compounds that could enhance the effectiveness of existing immunotherapies for melanoma.
- ucla.edu20:27
ScienceMag reported on a new five-year, $3.9 million National Cancer Institute grant awarded to UCLA’s Cristina Puig-Saus and her research team to develop new strategies to improve cancer immunotherapy. The researchers, based at the UCLA Health Jonsson Comprehensive Cancer Center, have created a fast, large-scale drug-screening platform to identify compounds that help T cells better recognize and destroy cancer cells. The work initially focuses on melanoma, but the approach could be expanded to...